Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Cardiovascular / Cardiology News

Neurosonix Wins Major European Cardiac Surgery Innovation Award

Main Category: Cardiovascular / Cardiology
Article Date: 01 Oct 2007 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Neurosonix Ltd., an Israeli company that developed non-invasive ultrasound-based embolic protection technologies for use in cardiac surgery and cath lab practice, is pleased to announce receiving the European Association of Cardio-Thoracic Surgery Techno-College Innovation Award for its first device, the EmBlocker™. This prestigious award was established to honor technological breakthroughs in all areas related to thoracic and cardiovascular research. The award was announced at a ceremony at the Annual Techno-College in Geneva, in front of an audience of over a 1,000 leading cardiac surgeons from around the world.

"We are honored that the EACTS has acknowledged the breakthrough we achieved in offering the cardiac surgeons and their patients a unique solution aimed at reducing the risk of brain injury following cardiac surgery", says Prof. Simcha Milo, inventor of the technology and co-founder of Neurosonix. "We are very excited that the EACTS recognized that the award-winning technology of the EmBlocker™ has the potential to change standard cardiac surgery practice".

Cerebral embolism is considered a major cause of brain injury during cardiac surgical procedures. Neurosonix first device, the EmBlocker™, uses proprietary ultrasound-based technology, to provide protection against cerebral embolism during open heart procedures. The EmBlocker™ uses ultrasonic energy to non-invasively divert emboli flow away from the cerebral arteries in order to reduce the risk of post-operative brain injury.

Prof. Jos Maessen, principal investigator of the pilot clinical study, Head of the Cardio- Thoracic Surgery Department at the Academic Hospital of Maastricht, the Netherlands, officially presented the results of the study at the 2007 EACTS Meeting. The study showed a significant decrease of over 65% of emboli flow to the brain in patients treated with the EmBlocker™.

"This is an important day for us, because the surgical community who faces the devastating results of brain injury, acknowledged the importance of the ground-breaking solution developed by Neurosonix", says Dr. Nathan Sela, Neurosonix CEO. "In addition, the audience of the Annual Techno-College comprised of worldwide key opinion leaders will be among the early adopters of the EmBlocker™".

Dr. Sela adds that "Neurosonix expects to release the EmBlocker™ to the European market during 2008".

About Neurosonix Ltd.

Neurosonix Ltd. is a medical device company founded in Israel in 2002, aimed at developing and marketing non-invasive ultrasound-based embolic protection technology and devices for use in cardiac surgery and cath lab practice. The company has a staff of 15 and is located in the Scientific Park of Rehovot, Israel. Neurosonix is backed by a strong group of investors, among which Elron Electronic Industries (NASDAQ: ELRN), Evergreen Venture Partners, Ofer Hitech and Peregrine Ventures. For more information, visit http://www.neurosonix.co.il.

About EACTS

The European Association of Cardio-Thoracic Surgery was founded in 1986. Its 2000 members are spread all over the world in all continents, representing some 70 countries. The main objects of the EACTS are to advance education in the field of cardiovascular and thoracic surgery, and to promote for the public benefit research in thoracic physiology, pathology and therapy and to correlate and disseminate the useful results thereof.

http://www.eacts.org/




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Hypertension? What Causes Hypertension?
15 May 2009
Hypertension or high blood pressure is a condition in which the blood pressure in the arteries is chronically elevated. With every heart beat, the heart pumps blood through the arteries to the rest of the body...


Stress and Sports image Stress and Sports

Many people turn to sports to unwind, but the pressure of competition can turn otherwise relaxing pursuits into sources of stress (and affect your game, too). Our panel of experts will discuss what you can do to make sure your sports life helps, rather than hurts, your state of mind...

Life After a Heart Transplant image Life After a Heart Transplant

Heart transplant success is determined by your post-surgery quality of life. Successful patients are able to resume activities they enjoyed before the procedure, such as moderate exercise and sexual activity. Join Dr. Mehmet Oz and ex-baseball star and donor-heart recipient Frank Torre, as they...

View more videos...